By Katherine Hamilton
Waters Corp. posted higher second-quarter revenue and narrowed its full-year outlook range thanks in part to strong demand for instrument replacement.
The maker of healthcare and science products on Monday posted a profit of $147.1 million, or $2.47 a share, in the second quarter, compared with $142.7 million, or $2.40 a share, a year earlier.
Stripping out certain one-time items, adjusted per-share earnings were $2.95, ahead of the $2.94 forecast by analysts, according to FactSet.
Revenue rose 8.9% to $771.3 million. Analysts surveyed by FactSet forecast revenue of $749 million.
The company raised the lower end of its full-year outlook to an adjusted earnings per share range of $12.95 to $13.05, up from $12.75 to $13.05. In the third quarter, Waters expects adjusted earnings per share to be $3.15 to $3.25.
Waters' results were driven by strong instrument replacement trends, driven by large pharmaceutical and contract development and manufacturing organization companies, Chief Executive Udit Batra said.
There was also incremental growth in its GLP-1, PFAS and generics sectors.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
August 04, 2025 06:32 ET (10:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.